nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioproperazine—ALB—type 2 diabetes mellitus	0.195	1	CbGaD
Thioproperazine—DRD1—Bromocriptine—type 2 diabetes mellitus	0.0768	0.118	CbGbCtD
Thioproperazine—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0615	0.0947	CbGbCtD
Thioproperazine—ALB—Gliclazide—type 2 diabetes mellitus	0.0585	0.09	CbGbCtD
Thioproperazine—ALB—Repaglinide—type 2 diabetes mellitus	0.055	0.0846	CbGbCtD
Thioproperazine—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0529	0.0815	CbGbCtD
Thioproperazine—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0506	0.0779	CbGbCtD
Thioproperazine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0486	0.0747	CbGbCtD
Thioproperazine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0467	0.0718	CbGbCtD
Thioproperazine—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0459	0.0706	CbGbCtD
Thioproperazine—ALB—Valsartan—type 2 diabetes mellitus	0.0405	0.0624	CbGbCtD
Thioproperazine—ALB—Nateglinide—type 2 diabetes mellitus	0.0377	0.058	CbGbCtD
Thioproperazine—SLC22A1—Metformin—type 2 diabetes mellitus	0.0263	0.0405	CbGbCtD
Thioproperazine—ALB—Glyburide—type 2 diabetes mellitus	0.0255	0.0392	CbGbCtD
Thioproperazine—ALB—Losartan—type 2 diabetes mellitus	0.0233	0.0358	CbGbCtD
Thioproperazine—HTR2A—arteriole—type 2 diabetes mellitus	0.00474	0.163	CbGeAlD
Thioproperazine—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00302	0.104	CbGeAlD
Thioproperazine—DRD1—nerve—type 2 diabetes mellitus	0.00293	0.101	CbGeAlD
Thioproperazine—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.00203	0.0698	CbGeAlD
Thioproperazine—HTR2A—hindlimb—type 2 diabetes mellitus	0.00188	0.0646	CbGeAlD
Thioproperazine—DRD2—nerve—type 2 diabetes mellitus	0.00173	0.0595	CbGeAlD
Thioproperazine—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.00146	0.0504	CbGeAlD
Thioproperazine—HTR2A—artery—type 2 diabetes mellitus	0.00115	0.0396	CbGeAlD
Thioproperazine—HTR2A—nerve—type 2 diabetes mellitus	0.00114	0.0393	CbGeAlD
Thioproperazine—ADRA1B—kidney—type 2 diabetes mellitus	0.00108	0.0371	CbGeAlD
Thioproperazine—HTR2A—endothelium—type 2 diabetes mellitus	0.000973	0.0334	CbGeAlD
Thioproperazine—SLC22A1—kidney—type 2 diabetes mellitus	0.000795	0.0273	CbGeAlD
Thioproperazine—DRD2—retina—type 2 diabetes mellitus	0.000717	0.0247	CbGeAlD
Thioproperazine—SLC22A1—adipose tissue—type 2 diabetes mellitus	0.000717	0.0246	CbGeAlD
Thioproperazine—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000671	0.0231	CbGeAlD
Thioproperazine—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000619	0.0213	CbGeAlD
Thioproperazine—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000546	0.0188	CbGeAlD
Thioproperazine—SLC22A1—liver—type 2 diabetes mellitus	0.000503	0.0173	CbGeAlD
Thioproperazine—ALB—liver—type 2 diabetes mellitus	0.000481	0.0165	CbGeAlD
Thioproperazine—HTR2A—retina—type 2 diabetes mellitus	0.000473	0.0163	CbGeAlD
Thioproperazine—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.0004	0.0138	CbGeAlD
Thioproperazine—HTR2A—kidney—type 2 diabetes mellitus	0.000391	0.0135	CbGeAlD
Thioproperazine—ADRA1A—liver—type 2 diabetes mellitus	0.000383	0.0132	CbGeAlD
Thioproperazine—Fluphenazine—CALM1—type 2 diabetes mellitus	0.00025	0.0401	CrCbGaD
Thioproperazine—HTR2A—liver—type 2 diabetes mellitus	0.000247	0.00851	CbGeAlD
Thioproperazine—Propericiazine—ADRA2A—type 2 diabetes mellitus	0.000212	0.034	CrCbGaD
Thioproperazine—Promethazine—CALM1—type 2 diabetes mellitus	0.000203	0.0325	CrCbGaD
Thioproperazine—Trifluoperazine—CALM1—type 2 diabetes mellitus	0.0002	0.0321	CrCbGaD
Thioproperazine—Perphenazine—CALM1—type 2 diabetes mellitus	0.000198	0.0317	CrCbGaD
Thioproperazine—Cyamemazine—HTR2C—type 2 diabetes mellitus	0.000195	0.0313	CrCbGaD
Thioproperazine—Chlorpromazine—CALM1—type 2 diabetes mellitus	0.000157	0.0252	CrCbGaD
Thioproperazine—Zuclopenthixol—ADRA2A—type 2 diabetes mellitus	0.000152	0.0244	CrCbGaD
Thioproperazine—Nefazodone—ADRA2A—type 2 diabetes mellitus	0.000151	0.0242	CrCbGaD
Thioproperazine—Trazodone—ADRA2A—type 2 diabetes mellitus	0.00014	0.0224	CrCbGaD
Thioproperazine—Nefazodone—HTR2C—type 2 diabetes mellitus	0.000139	0.0223	CrCbGaD
Thioproperazine—Thiothixene—ADRA2A—type 2 diabetes mellitus	0.000131	0.021	CrCbGaD
Thioproperazine—Trazodone—HTR2C—type 2 diabetes mellitus	0.000129	0.0206	CrCbGaD
Thioproperazine—Thiothixene—HTR2C—type 2 diabetes mellitus	0.000121	0.0193	CrCbGaD
Thioproperazine—Mesoridazine—HTR2C—type 2 diabetes mellitus	0.000119	0.0191	CrCbGaD
Thioproperazine—Prochlorperazine—HTR2C—type 2 diabetes mellitus	0.000115	0.0185	CrCbGaD
Thioproperazine—Fluphenazine—ADRA2A—type 2 diabetes mellitus	0.000113	0.0181	CrCbGaD
Thioproperazine—Fluphenazine—HTR2C—type 2 diabetes mellitus	0.000104	0.0167	CrCbGaD
Thioproperazine—Clomipramine—ADRA2A—type 2 diabetes mellitus	0.000103	0.0166	CrCbGaD
Thioproperazine—Propiomazine—HTR2C—type 2 diabetes mellitus	0.0001	0.0161	CrCbGaD
Thioproperazine—Alimemazine—CYP3A4—type 2 diabetes mellitus	9.83e-05	0.0158	CrCbGaD
Thioproperazine—Thioridazine—ADRA2A—type 2 diabetes mellitus	9.75e-05	0.0156	CrCbGaD
Thioproperazine—Clomipramine—HTR2C—type 2 diabetes mellitus	9.53e-05	0.0153	CrCbGaD
Thioproperazine—Methotrimeprazine—ADRA2A—type 2 diabetes mellitus	9.31e-05	0.0149	CrCbGaD
Thioproperazine—Pipotiazine—CYP1A2—type 2 diabetes mellitus	9.09e-05	0.0146	CrCbGaD
Thioproperazine—Thiothixene—CYP1A2—type 2 diabetes mellitus	9.09e-05	0.0146	CrCbGaD
Thioproperazine—Thioridazine—HTR2C—type 2 diabetes mellitus	8.97e-05	0.0144	CrCbGaD
Thioproperazine—Perphenazine—ADRA2A—type 2 diabetes mellitus	8.95e-05	0.0143	CrCbGaD
Thioproperazine—Quetiapine—ADRA2A—type 2 diabetes mellitus	8.77e-05	0.0141	CrCbGaD
Thioproperazine—Methotrimeprazine—HTR2C—type 2 diabetes mellitus	8.57e-05	0.0137	CrCbGaD
Thioproperazine—Mequitazine—CYP3A4—type 2 diabetes mellitus	8.46e-05	0.0136	CrCbGaD
Thioproperazine—Trifluoperazine—HTR2C—type 2 diabetes mellitus	8.33e-05	0.0134	CrCbGaD
Thioproperazine—Fluphenazine—CYP2E1—type 2 diabetes mellitus	8.26e-05	0.0133	CrCbGaD
Thioproperazine—Perphenazine—HTR2C—type 2 diabetes mellitus	8.24e-05	0.0132	CrCbGaD
Thioproperazine—Quetiapine—HTR2C—type 2 diabetes mellitus	8.08e-05	0.013	CrCbGaD
Thioproperazine—Promazine—ADRA2A—type 2 diabetes mellitus	8.06e-05	0.0129	CrCbGaD
Thioproperazine—Fluphenazine—CYP1A2—type 2 diabetes mellitus	7.86e-05	0.0126	CrCbGaD
Thioproperazine—Promazine—HTR2C—type 2 diabetes mellitus	7.42e-05	0.0119	CrCbGaD
Thioproperazine—Clomipramine—CYP1A2—type 2 diabetes mellitus	7.19e-05	0.0115	CrCbGaD
Thioproperazine—Thioridazine—CYP2E1—type 2 diabetes mellitus	7.12e-05	0.0114	CrCbGaD
Thioproperazine—Chlorpromazine—ADRA2A—type 2 diabetes mellitus	7.1e-05	0.0114	CrCbGaD
Thioproperazine—Nefazodone—CYP3A4—type 2 diabetes mellitus	6.94e-05	0.0111	CrCbGaD
Thioproperazine—Methotrimeprazine—CYP2E1—type 2 diabetes mellitus	6.8e-05	0.0109	CrCbGaD
Thioproperazine—Thioridazine—CYP1A2—type 2 diabetes mellitus	6.77e-05	0.0109	CrCbGaD
Thioproperazine—Chlorpromazine—HTR2C—type 2 diabetes mellitus	6.53e-05	0.0105	CrCbGaD
Thioproperazine—Imipramine—HTR2C—type 2 diabetes mellitus	6.5e-05	0.0104	CrCbGaD
Thioproperazine—Methotrimeprazine—CYP1A2—type 2 diabetes mellitus	6.46e-05	0.0104	CrCbGaD
Thioproperazine—Trazodone—CYP3A4—type 2 diabetes mellitus	6.42e-05	0.0103	CrCbGaD
Thioproperazine—Trifluoperazine—CYP1A2—type 2 diabetes mellitus	6.28e-05	0.0101	CrCbGaD
Thioproperazine—Perphenazine—CYP1A2—type 2 diabetes mellitus	6.21e-05	0.00997	CrCbGaD
Thioproperazine—Pipotiazine—CYP3A4—type 2 diabetes mellitus	6.02e-05	0.00966	CrCbGaD
Thioproperazine—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	5.75e-05	0.00923	CrCbGaD
Thioproperazine—Promazine—CYP1A2—type 2 diabetes mellitus	5.6e-05	0.00899	CrCbGaD
Thioproperazine—Acepromazine—ALB—type 2 diabetes mellitus	5.46e-05	0.00876	CrCbGaD
Thioproperazine—Pipotiazine—ALB—type 2 diabetes mellitus	5.25e-05	0.00842	CrCbGaD
Thioproperazine—Thiothixene—ALB—type 2 diabetes mellitus	5.25e-05	0.00842	CrCbGaD
Thioproperazine—Chlorpromazine—CYP2E1—type 2 diabetes mellitus	5.18e-05	0.00831	CrCbGaD
Thioproperazine—Imipramine—CYP2E1—type 2 diabetes mellitus	5.16e-05	0.00827	CrCbGaD
Thioproperazine—Chlorpromazine—CYP1A2—type 2 diabetes mellitus	4.93e-05	0.00791	CrCbGaD
Thioproperazine—Imipramine—CYP1A2—type 2 diabetes mellitus	4.9e-05	0.00787	CrCbGaD
Thioproperazine—Clomipramine—CYP3A4—type 2 diabetes mellitus	4.76e-05	0.00763	CrCbGaD
Thioproperazine—Clomipramine—ALB—type 2 diabetes mellitus	4.15e-05	0.00666	CrCbGaD
Thioproperazine—Perphenazine—CYP3A4—type 2 diabetes mellitus	4.11e-05	0.0066	CrCbGaD
Thioproperazine—Quetiapine—CYP3A4—type 2 diabetes mellitus	4.03e-05	0.00647	CrCbGaD
Thioproperazine—Promazine—CYP3A4—type 2 diabetes mellitus	3.71e-05	0.00595	CrCbGaD
Thioproperazine—Chlorpromazine—CYP3A4—type 2 diabetes mellitus	3.26e-05	0.00524	CrCbGaD
Thioproperazine—Imipramine—CYP3A4—type 2 diabetes mellitus	3.25e-05	0.00521	CrCbGaD
Thioproperazine—Chlorpromazine—ALB—type 2 diabetes mellitus	2.85e-05	0.00457	CrCbGaD
Thioproperazine—DRD2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	8.23e-06	6.86e-05	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—CALM1—type 2 diabetes mellitus	8.22e-06	6.85e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.22e-06	6.85e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—IGF2—type 2 diabetes mellitus	8.22e-06	6.85e-05	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—APOE—type 2 diabetes mellitus	8.19e-06	6.83e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	8.19e-06	6.83e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	8.18e-06	6.82e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.12e-06	6.77e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—APOB—type 2 diabetes mellitus	8.11e-06	6.76e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.1e-06	6.75e-05	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—APOA1—type 2 diabetes mellitus	8.1e-06	6.75e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	8.1e-06	6.75e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—AVP—type 2 diabetes mellitus	8.08e-06	6.73e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	8.08e-06	6.73e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	8.07e-06	6.73e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	8.04e-06	6.7e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	8.01e-06	6.68e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.98e-06	6.65e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—APOB—type 2 diabetes mellitus	7.98e-06	6.65e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.94e-06	6.62e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—C3—type 2 diabetes mellitus	7.94e-06	6.62e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	7.93e-06	6.61e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.88e-06	6.56e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.85e-06	6.54e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—APOB—type 2 diabetes mellitus	7.81e-06	6.51e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.78e-06	6.48e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—LPL—type 2 diabetes mellitus	7.74e-06	6.45e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.73e-06	6.45e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.69e-06	6.41e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.67e-06	6.39e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—LPL—type 2 diabetes mellitus	7.62e-06	6.35e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.58e-06	6.32e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.57e-06	6.31e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—C3—type 2 diabetes mellitus	7.56e-06	6.3e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.55e-06	6.29e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—AGT—type 2 diabetes mellitus	7.54e-06	6.29e-05	CbGpPWpGaD
Thioproperazine—ALB—Hemostasis—SRC—type 2 diabetes mellitus	7.49e-06	6.24e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—LPL—type 2 diabetes mellitus	7.46e-06	6.22e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.46e-06	6.21e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.41e-06	6.18e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—APOE—type 2 diabetes mellitus	7.39e-06	6.16e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—LEP—type 2 diabetes mellitus	7.39e-06	6.16e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—INS—type 2 diabetes mellitus	7.34e-06	6.12e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.3e-06	6.09e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.3e-06	6.08e-05	CbGpPWpGaD
Thioproperazine—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	7.3e-06	6.08e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.26e-06	6.05e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.22e-06	6.02e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.21e-06	6.01e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.19e-06	5.99e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—GNB3—type 2 diabetes mellitus	7.18e-06	5.99e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.18e-06	5.99e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—AGT—type 2 diabetes mellitus	7.18e-06	5.99e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	7.15e-06	5.96e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.14e-06	5.96e-05	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—PPARG—type 2 diabetes mellitus	7.14e-06	5.95e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.13e-06	5.94e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.1e-06	5.92e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.09e-06	5.91e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.06e-06	5.89e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.06e-06	5.89e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—CAT—type 2 diabetes mellitus	7.05e-06	5.88e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—LEP—type 2 diabetes mellitus	7.04e-06	5.86e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—APOE—type 2 diabetes mellitus	7.04e-06	5.86e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.02e-06	5.85e-05	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—INS—type 2 diabetes mellitus	7e-06	5.83e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7e-06	5.83e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—C3—type 2 diabetes mellitus	6.97e-06	5.81e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.97e-06	5.81e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.96e-06	5.8e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.87e-06	5.73e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—C3—type 2 diabetes mellitus	6.86e-06	5.71e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—APOB—type 2 diabetes mellitus	6.85e-06	5.71e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.74e-06	5.62e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—C3—type 2 diabetes mellitus	6.71e-06	5.6e-05	CbGpPWpGaD
Thioproperazine—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	6.7e-06	5.58e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	6.66e-06	5.55e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.65e-06	5.54e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.64e-06	5.53e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.63e-06	5.53e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—AGT—type 2 diabetes mellitus	6.62e-06	5.52e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.59e-06	5.49e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—LPL—type 2 diabetes mellitus	6.54e-06	5.45e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.54e-06	5.45e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.52e-06	5.44e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—AGT—type 2 diabetes mellitus	6.51e-06	5.43e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.51e-06	5.43e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—APOE—type 2 diabetes mellitus	6.49e-06	5.41e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—LEP—type 2 diabetes mellitus	6.49e-06	5.41e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.44e-06	5.37e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.44e-06	5.37e-05	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	6.42e-06	5.35e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.41e-06	5.35e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.41e-06	5.34e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.4e-06	5.34e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	6.4e-06	5.34e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.39e-06	5.32e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—LEP—type 2 diabetes mellitus	6.38e-06	5.32e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—APOE—type 2 diabetes mellitus	6.38e-06	5.32e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—GPX1—type 2 diabetes mellitus	6.38e-06	5.32e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—AGT—type 2 diabetes mellitus	6.38e-06	5.32e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—INS—type 2 diabetes mellitus	6.31e-06	5.26e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.31e-06	5.26e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.28e-06	5.23e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.27e-06	5.23e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—LEP—type 2 diabetes mellitus	6.25e-06	5.21e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—APOE—type 2 diabetes mellitus	6.25e-06	5.21e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—CD36—type 2 diabetes mellitus	6.21e-06	5.18e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.21e-06	5.18e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.18e-06	5.15e-05	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	6.14e-06	5.12e-05	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	6.14e-06	5.12e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	6.14e-06	5.11e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.12e-06	5.1e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.11e-06	5.09e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.1e-06	5.09e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.08e-06	5.06e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—RELA—type 2 diabetes mellitus	6.06e-06	5.05e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.02e-06	5.02e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—INS—type 2 diabetes mellitus	6.01e-06	5.01e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.91e-06	4.93e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.89e-06	4.91e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	5.89e-06	4.91e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.81e-06	4.85e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.81e-06	4.84e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.8e-06	4.83e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.79e-06	4.82e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.79e-06	4.82e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—PPARA—type 2 diabetes mellitus	5.78e-06	4.81e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.69e-06	4.75e-05	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	5.61e-06	4.68e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—AGT—type 2 diabetes mellitus	5.59e-06	4.66e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.58e-06	4.65e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	5.54e-06	4.62e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.54e-06	4.61e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.54e-06	4.61e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.52e-06	4.6e-05	CbGpPWpGaD
Thioproperazine—DRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.52e-06	4.6e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—CALM1—type 2 diabetes mellitus	5.5e-06	4.58e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—APOE—type 2 diabetes mellitus	5.48e-06	4.57e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.47e-06	4.56e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—INS—type 2 diabetes mellitus	5.45e-06	4.55e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.45e-06	4.54e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.43e-06	4.53e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—APOA1—type 2 diabetes mellitus	5.42e-06	4.52e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.37e-06	4.47e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.36e-06	4.47e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.36e-06	4.46e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	5.34e-06	4.45e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.33e-06	4.45e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.27e-06	4.4e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.27e-06	4.39e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.27e-06	4.39e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.27e-06	4.39e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.25e-06	4.38e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.25e-06	4.37e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	5.21e-06	4.34e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.16e-06	4.3e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.16e-06	4.3e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.16e-06	4.3e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.14e-06	4.28e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.11e-06	4.26e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.09e-06	4.24e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.01e-06	4.18e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.01e-06	4.17e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—RELA—type 2 diabetes mellitus	4.96e-06	4.14e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.9e-06	4.09e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.86e-06	4.05e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.86e-06	4.05e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.78e-06	3.99e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.78e-06	3.99e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—PPARG—type 2 diabetes mellitus	4.77e-06	3.98e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.76e-06	3.97e-05	CbGpPWpGaD
Thioproperazine—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.74e-06	3.95e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.7e-06	3.92e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—INS—type 2 diabetes mellitus	4.68e-06	3.9e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.68e-06	3.9e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.68e-06	3.9e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.67e-06	3.89e-05	CbGpPWpGaD
Thioproperazine—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	4.66e-06	3.88e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.64e-06	3.87e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	4.57e-06	3.81e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.52e-06	3.77e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	4.5e-06	3.75e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.48e-06	3.73e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.45e-06	3.71e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.44e-06	3.7e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	4.41e-06	3.67e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.39e-06	3.66e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.31e-06	3.59e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.26e-06	3.55e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.23e-06	3.53e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.18e-06	3.49e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.17e-06	3.48e-05	CbGpPWpGaD
Thioproperazine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.16e-06	3.47e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.13e-06	3.44e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—NOS3—type 2 diabetes mellitus	4.11e-06	3.42e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	4.11e-06	3.42e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.1e-06	3.42e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.1e-06	3.42e-05	CbGpPWpGaD
Thioproperazine—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.1e-06	3.42e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	4.09e-06	3.41e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.06e-06	3.38e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.03e-06	3.36e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.01e-06	3.34e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.99e-06	3.32e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.98e-06	3.31e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.95e-06	3.29e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	3.9e-06	3.25e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.9e-06	3.25e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.86e-06	3.22e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.84e-06	3.2e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.8e-06	3.17e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.8e-06	3.16e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.78e-06	3.15e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.76e-06	3.13e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	3.76e-06	3.13e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.72e-06	3.1e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.72e-06	3.1e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.66e-06	3.05e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.64e-06	3.04e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	3.6e-06	3e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.59e-06	2.99e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	3.54e-06	2.95e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.5e-06	2.92e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.49e-06	2.91e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	3.46e-06	2.89e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.45e-06	2.87e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.42e-06	2.85e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.37e-06	2.81e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.21e-06	2.68e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.21e-06	2.67e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.16e-06	2.64e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.15e-06	2.63e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.1e-06	2.58e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.1e-06	2.58e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.04e-06	2.53e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.96e-06	2.47e-05	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	2.82e-06	2.35e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.76e-06	2.3e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	2.63e-06	2.19e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.54e-06	2.12e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.42e-06	2.02e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.42e-06	2.02e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.38e-06	1.99e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.33e-06	1.94e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.23e-06	1.86e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.2e-06	1.83e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.15e-06	1.79e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—AKT1—type 2 diabetes mellitus	1.89e-06	1.57e-05	CbGpPWpGaD
